Pangea Biomed
Biotechnology, Health Care, Medical
Founded in 1/1/18
Tel Aviv, Tel Aviv, Israel
For Profit
About Pangea Biomed
Pangea Biomed combines ML and RNA sequencing to offer personalized cancer treatment. The company's ENLIGHT platform can surface relevant biological insights to pinpoint the best path forward in combating a patient's cancer by combining the hidden power of RNA sequencing with ML-enabled network effects. It examines the molecular context in which targeted therapies operate, looking beyond actionable genomic abnormalities. Pangea's goal is to democratize precision oncology, bringing deep tumor intelligence to drug development and to treatment nomination for patients.
Company Metrics
- Employees: 11-50
- Monthly Visits: 2626
- Tech Stack: None active products
Financial Information
- Estimated Revenue:
- Total Funding: 12000000 USD
- Last Funding: 5000000 USD (Seed)
- Funding Status: Seed
Technology Stack
Pangea Biomed actively uses None products in their tech stack.
Market Presence
Industries: Biotechnology, Health Care, Medical
Headquarters: Tel Aviv, Tel Aviv, Israel
Employees
- Ranit Aharonov - Chief Technology Officer (LinkedIn)